Affidea Spain closes 2022 with all its CT centers included in the prestigious EuroSafe Imaging Wall of Stars


19/12/2022
  • The European Society of Radiology has incorporated them into the EuroSafe Imaging Wall of Stars and has accredited them with 5 stars for patient radiation dose control.

Madrid, December 19, 2022-. Affidea, the largest European provider of advanced diagnostic, outpatient and oncology services, closes the year in Spain with excellent news: all of its computed tomography (CT)* centers in our country have been recognized by the European Society of Radiology (ESR), which has incorporated them into the EuroSafe Imaging Wall of Stars and has accredited them with 5 stars in the control of radiation dose to patients. Of all the centers in the world with 5 stars on the Eurosafe Imaging Wall of Stars, 53% are Affidea centers, demonstrating the company's firm commitment to patient safety.

'EuroSafe Imaging Stars is an ESR initiative designed to identify and recognize radiodiagnostic facilities around the world that incorporate best practices in radiation protection. The mission of EuroSafe Imaging is to support and strengthen medical radiation protection across Europe following a comprehensive and inclusive approach. The initiative was launched in early 2016 to raise the profile of radiation protection while having a positive impact on clinical practice. To participate in the EuroSafe Imaging Stars initiative, centers must complete an online self-assessment of their level of radiation protection.

Theo Kravvas, CEO of Affidea Spain, points out that "our commitment is to offer healthcare services of the highest level of quality to our patients. This requires a daily focus and effort to create and maintain high-level procedures in clinical practice. It is not enough to communicate this message to physicians and patients, it is also important to demonstrate it. We are very pleased to announce today that all Affidea Spain diagnostic imaging centers operating CT equipment are accredited with 5 stars in radiological protection for patients and healthcare professionals. I would like to personally thank our clinical and quality team for this excellent achievement.

For his part, Dr. Pedro Bustillo, Medical Director at Affidea Spain, states that "a priority objective at Affidea is to obtain maximum diagnostic performance with the lowest possible radiation; in other words, we have the unavoidable mission of offering maximum radiological protection to our patients. This has been achieved, after intense work, with the development of our dose control program, and has been recognized and accredited by the ESR, which means satisfaction and pride in the work done by the entire team of Affidea's large team of healthcare and non-healthcare professionals involved in the project. This official ESR accreditation should mean peace of mind for our patients about the radiation protection standards that prevail at Affidea."

*Affidea Clínica Tesla, Affidea Grup Manchón Tibidabo, Affidea Hospital Fuensanta, Affidea Hospital Mesa del Castillo, Affidea Hospital Sagrado Corazón, Affidea Hospital Santísima Trinidad, Affidea Hospital Virgen del Alcazar, Affidea Hospital VOT.

About Affidea Spain

Affidea España (www.affidea.es) is a leading medical provider of diagnostic imaging, nuclear medicine and outpatient medical specialties, with 43 centers nationwide. Affidea España performs more than 900,000 diagnostic imaging examinations each year, offering a medical service of excellence at the forefront of patient care. The company works with more than 1,100 professionals. Affidea Spain is recognized for its focus on patient safety, having all its centers accredited for excellence in nuclear medicine by the European Union of Medical Specialties (UEMS) and the European Board of Nuclear Medicine (EBNM), as well as all centers with CT accredited by the European Society of Radiology in Europe, in the EuroSafe Imaging Wall of Stars.

Media contact: Elena Ayuso - 656 321 906 - elena.ayuso@affidea.com - ES_prensa@affidea.com

About Affidea Group

Affidea Group (www.affidea.com) is Europe's largest provider of advanced diagnostic imaging, outpatient and cancer treatment services. Founded in 1991, the company operates 330 medical centers in 15 countries and provides advanced diagnostic, outpatient and cancer treatment services to more than 12 million patients a year. Thanks to its high standards in patient safety, Affidea is the most awarded provider of medical imaging services in Europe. More than half of the centers awarded 5 stars in the Eurosafe Wall of Stars, accredited by the European Society of Radiology in Europe, are Affidea centers. In June this year, Affidea was awarded the Diagnostic Provider of the Year Award at the HealthInvestor Awards 2022.